Manualized therapy + Midomafetamine HCl for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Mar 2018: Trial started, NCT03485287
  2. 2 Apr 2018: Trial registered, NCT03485287

The trials

NCT03485287: Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)

State
Completed
Phase
Phase 2
People
4 taking part
Started
13 Mar 2018
Primary completion
4 Jun 2019
Arms
MDMA-assisted therapy
Results
Posted on the registry
  1. 13 Mar 2018: Trial started
  2. 2 Apr 2018: Trial registered
  3. 4 Jun 2019: Trial completed
  4. 1 Jul 2021: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.